Rook EJ - Search Results

1

Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature.

Rook EJ, Huitema AD, van den Brink W, van Ree JM, Beijnen JH. Rook EJ, et al. Curr Clin Pharmacol. 2006 Jan;1(1):109-18. doi: 10.2174/157488406775268219. Curr Clin Pharmacol. 2006. PMID: 18666382 Review.

2

Pharmacokinetic comparison of two methods of heroin smoking: 'chasing the dragon' versus the use of a heating device.

Klous MG, Huitema AD, Rook EJ, Hillebrand MJ, Hendriks VM, Van den Brink W, Beijnen JH, Van Ree JM. Klous MG, et al. Among authors: rook ej. Eur Neuropsychopharmacol. 2005 May;15(3):263-9. doi: 10.1016/j.euroneuro.2004.12.001. Eur Neuropsychopharmacol. 2005. PMID: 15820414 Clinical Trial.

3

The quantitative analysis of heroin, methadone and their metabolites and the simultaneous detection of cocaine, acetylcodeine and their metabolites in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry.

Rook EJ, Hillebrand MJ, Rosing H, van Ree JM, Beijnen JH. Rook EJ, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Sep 25;824(1-2):213-21. doi: 10.1016/j.jchromb.2005.05.048. J Chromatogr B Analyt Technol Biomed Life Sci. 2005. PMID: 16103023

4

Deuterodiacetylmorphine as a marker for use of illicit heroin by addicts in a heroin-assisted treatment program.

Klous MG, Rook EJ, Hillebrand MJ, van den Brink W, van Ree JM, Beijnen JH. Klous MG, et al. Among authors: rook ej. J Anal Toxicol. 2005 Sep;29(6):564-9. doi: 10.1093/jat/29.6.564. J Anal Toxicol. 2005. PMID: 16168180

5

Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients.

Rook EJ, van Ree JM, van den Brink W, Hillebrand MJ, Huitema AD, Hendriks VM, Beijnen JH. Rook EJ, et al. Basic Clin Pharmacol Toxicol. 2006 Jan;98(1):86-96. doi: 10.1111/j.1742-7843.2006.pto_233.x. Basic Clin Pharmacol Toxicol. 2006. PMID: 16433897 Free article. Clinical Trial.

6

Population pharmacokinetics of heroin and its major metabolites.

Rook EJ, Huitema AD, van den Brink W, van Ree JM, Beijnen JH. Rook EJ, et al. Clin Pharmacokinet. 2006;45(4):401-17. doi: 10.2165/00003088-200645040-00005. Clin Pharmacokinet. 2006. PMID: 16584286 Clinical Trial.

7

Mast cell mediator tryptase levels after inhalation or intravenous administration of high doses pharmaceutically prepared heroin.

Rook EJ, van Zanten AP, Van den Brink W, van Ree JM, Beijnen JH. Rook EJ, et al. Drug Alcohol Depend. 2006 Dec 1;85(3):185-90. doi: 10.1016/j.drugalcdep.2006.04.013. Epub 2006 Jun 12. Drug Alcohol Depend. 2006. PMID: 16765536 Clinical Trial.

8

Screening for illicit heroin use in patients in a heroin-assisted treatment program.

Rook EJ, Huitema AD, van den Brink W, Hillebrand MJ, van Ree JM, Beijnen JH. Rook EJ, et al. J Anal Toxicol. 2006 Jul-Aug;30(6):390-4. doi: 10.1093/jat/30.6.390. J Anal Toxicol. 2006. PMID: 16872571

9

Heroin-assisted treatment in the Netherlands: History, findings, and international context.

Blanken P, van den Brink W, Hendriks VM, Huijsman IA, Klous MG, Rook EJ, Wakelin JS, Barendrecht C, Beijnen JH, van Ree JM. Blanken P, et al. Among authors: rook ej. Eur Neuropsychopharmacol. 2010 Apr;20 Suppl 2:S105-58. doi: 10.1016/S0924-977X(10)70001-8. Eur Neuropsychopharmacol. 2010. PMID: 20362236

10

Use of Opioids Increases With Age in Older Adults: An Observational Study (2005-2017).

Weesie YM, Hek K, Schermer TRJ, Schellevis FG, Leufkens HGM, Rook EJ, van Dijk L. Weesie YM, et al. Among authors: rook ej. Front Pharmacol. 2020 May 14;11:648. doi: 10.3389/fphar.2020.00648. eCollection 2020. Front Pharmacol. 2020. PMID: 32477127 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results